July 15, 2026 | Korea Biotech Breaks New Ground

Issue #44 · July 15

View Archive | Subscribe | Partners With Us

From Members to Global: Covering the Entire Bio Industry

Korea breaks new ground with innovative therapies, global partnerships and emerging technologies!✨

This week's edition highlights first-of-its-kind clinical advances, international collaborations, and key developments driving Korea’s biohealth industry forward.

Stay tuned till the end for more K-Bio updates!

THIS WEEK:

Samsung Bioepis and PROTEINA partner to develop AI-driven novel antibody drugs

Samsung Bioepis is embarking on the joint development of novel antibody drugs utilizing artificial intelligence with PROTEINA, an AI-driven drug development company. — Asiatoday

Korean smart farms bolster Middle East food security with $2.6 mil. UAE deal Faced with heightened geopolitical instability and the persistent threat of maritime disruptions in the Strait of Hormuz, Persian Gulf nations are moving aggressively to secure their domestic food supply chains. — The Korea Times

Rokit Healthcare Launches World's First Kidney Regeneration Clinical Trial It marks the world's first attempt to verify the regenerative potential of kidney tissue using a patch derived from cells taken from the patient's own fat membrane tissue (omentum). — Seoul Economic Daily

EDITOR'S NOTE

Greetings from Taipei !

KoreaBIO is currently on-site at BIO Asia-Taiwan 2026 😎

Connecting with global biotech leaders and exploring new opportunities, we look forward to seeing you at the Korea Session this Friday!

Already registered?

Be sure to mark your calendar and join us!

Not registered yet?

Don't miss this opportunity to discover the latest trends in the Korea biotech industry, along with emerging investment and partnership opportunities.

Event Details & Registration →

KoreaBIO MEMBER NEWS

#Member_Services #Benefits

Bio Bridge Bootcamp | July 8

A practical bootcamp supporting technology commercialization by providing strategic guidance and personalized 1:1 expert consulting for companies preparing to enter the nonclinical or clinical stage.🚀

Bilix Selected as Korea's Representative for ‘Startup World Cup 2026’, Heading to San Fransisco.

WOOJUNG BIO Renamed ‘Kolmar BioTech’ to Strengthen Core Business and Expand New Ventures.

C&R Research to Host July Webinar on Advancing PMS into RWE-Based Post-Marketing Research Strategies.

Oscotec Highlights ACART Platform and Anticancer Pipeline Expansion Potential as OSCOTEC 2026 R&D DAY.

Dt&CRO Aims to Become a Strategic Partner in Successful Drug Development, Says Vice Chairman Han Tae-Dong.

C&R Research Acquires EPS International Korea to Establish Korea-China-Japan Clinical Trial Platform.

Savvy Robotics Advances Bioprocess Automation with the World’s Only Bio-Specific Robotics Platform.

Insilicogen to Host 77th INCO Seminar Online on Biomarker Discovery Strategies Using Public Omics Data.

Protium Science Strengthens Analytical Capabilities with High-Throughput Particle Analyzer 'Aura'.

C&R Research Envisions Future of Data CRO, Where AI Supports Human-Led Decision Making.

👥 View More Members Companies

Here's what's happening across Korea's bio industry!

WHAT'S HAPPENING

KOREA GOES GLOBAL

∎ Celltrion Expands Europe Market Share - Business Korea
∎ D&D Pharmatech Wins Additional Pfizer Order, Expands Obesity Drug Deal 38% - Seoul Economic Daily
∎ Samsung Bioepis Partners with Teva for OPUVIZ® in Canada - Business Korea
∎ SK bioscience Reaffirms Global GMP Excellence by Completing WHO Review - Business Korea
∎ Y-Biologics secures U.S. patent for B7-H3 antibody targeting solid tumors, strengthening its global IP portfolio - THE BIO
∎ Aribio Receives $60 Million from China's Puxing Pharmaceutical to Accelerate AR1001 Commercialization - Aju Press
∎ Cosmax expands AI-powered personalized cosmetics to Japan in 1st overseas venture - KBR

INNOVATION & TRENDS

∎ Korea's Daewoong Pharma teams up with Waycen to enter AI endoscope software market - BioSpectrum Asia
∎ Noul's miLab MAL highlighted as leading AI malaria diagnostic in Harvard-led international study - KBR
∎ Hyundai Motor opens first waste-to-hydrogen facility in Korea - The Korea Herald
∎ Gut Microbes Reduce Stress-Induced Depression-like Behaviors... Mechanism of Brain Signal Restoration Identified - The Asia Business Daily
∎ NewCos Are Rising in Korea’s Biotech Technology Transfer Market - The Asia Business Daily
∎ Korea's next drug lab is in orbit - The Korea Herald
∎ Korea food firms pivot to digital health as obesity climbs despite zero sugar - Chosun Biz

GROWTH & PERFORMANCE

∎ Korean Biotech Eyes Second-Half Catalysts After BIO USA - Hit News
∎ South Korea Eases Regulations for Biosimilar Development - Aju Press
∎ Samsung Bioepis Secures PH20 SC Formulation Platform - Business Korea
∎ Daewoong Pharmaceutical's Enblo Improves Fatty Liver in 67% of Patients - Aju Press

∎ D&D Pharmatech initiates Phase 2 trial of out-licensed FAP-targeted asset, milestone payment expected - THE BIO
∎ D&D Pharmatech Secures Japanese Patent for MASH Treatment 'Zabofegdutide' - The Asia Business Daily
∎ GC Cell's ImmunCell-LC Injection Officially Listed in WHO Antineoplastic Cell and Gene Therapy Classification - The Asia Business Daily

📰 View Lastest KoreaBIO News

WHAT WE'VE BEEN UP TO

Training

A practical training course on medical device health insurance and new health technology assessment was provided for industry professionals from July 8 to 9.

More Photos →

WHAT'S COMING UP?